Intrapulmonary Administration of Leukotriene B4 Enhances Pulmonary Host Defense against Pneumococcal Pneumonia -- Mancuso et al. 78 (5): 2264 Data Supplement - Supplemental material -- Infection and Immunity

Intrapulmonary Administration of Leukotriene B₄ Enhances Pulmonary Host Defense against Pneumococcal Pneumonia
Infect. Immun. Mancuso et al. 78: 2264

Supplemental material

Files in this Data Supplement:

Supplemental file 1 - Fig. S1. Aerosolized LTB₄ administered 24 h after S. pneumoniae challenge reduces pulmonary bacterial burdens at doses greater than 100 ng.
Fig. S2. Effect of aerosolized LTB₄ on lung cytokine levels in mice with pneumococcal pneumonia.
MS PowerPoint file, 154K.